A AstraZeneca
Swedish-British pharmaceutical company
Updates & Highlights
Recent Openings
View all 10 jobs arrow_forwardAll Jobs
Associate Principal AI Research Scientist (Fundamental AI Research for Digital Biology)
location_on Boston, MA, US
Associate Principal AI& ML Engineer – Evinova
location_on London, ENG, GB
Associate Principal AI Research Scientist (Fundamental AI Research for Digital Biology)
location_on Wilmington, DE, US
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at AstraZeneca?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentAstraZeneca Eyes India Launch for Oral GLP-1 Drug
AstraZeneca Eyes India Launch for Oral GLP-1 Drug
NAVLIN DAILY · 1 day ago
AstraZeneca talks offer new hope of breast cancer drug on NHS
AstraZeneca talks offer new hope of breast cancer drug on NHS
The Times · 2 days ago
AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback
AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback
simplywall.st · 4 days ago
AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback
AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback
Yahoo Finance · 4 days ago
Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note
Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note
Yahoo Finance · 5 days ago
Grant Funding Opportunity From AstraZeneca is Now Accepting Applications! - Conquer Cancer
Grant Funding Opportunity From AstraZeneca is Now Accepting Applications! - Conquer Cancer
Oncodaily · 6 days ago
Physician Views Preview: Can a popular plus-one give AstraZeneca's elecoglipron clout in the oral GLP-1 party?
Physician Views Preview: Can a popular plus-one give AstraZeneca's elecoglipron clout in the oral GLP-1 party?
FirstWord Pharma · 6 days ago
Astrazeneca shares it's dedication to getting new medicine in Americans' hands quickly
Astrazeneca shares it's dedication to getting new medicine in Americans' hands quickly
WUSA9 · 6 days ago
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials
Yahoo Finance · 6 days ago
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials
AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials
Yahoo Finance Singapore · 6 days ago
AstraZeneca expands oncology portfolio with Truqap nod in PTEN-deficient metastatic prostate cancer
AstraZeneca expands oncology portfolio with Truqap nod in PTEN-deficient metastatic prostate cancer
Новости GxP · 6 days ago
The Zacks Analyst Blog Highlights Applied Materials, GE, AstraZeneca, Team and Applied Energetics
The Zacks Analyst Blog Highlights Applied Materials, GE, AstraZeneca, Team and Applied Energetics
Zacks Investment Research · 7 days ago
Key facts: AstraZeneca awaits lung trial readout; warns German pricing
Key facts: AstraZeneca awaits lung trial readout; warns German pricing
TradingView · 7 days ago
How AstraZeneca’s $50 billion investment is shaping the future of medicine
How AstraZeneca’s $50 billion investment is shaping the future of medicine
KUTV · 7 days ago
Top Stock Reports for Applied Materials, GE & AstraZeneca
Top Stock Reports for Applied Materials, GE & AstraZeneca
Yahoo Finance · 7 days ago
AstraZeneca (AZN) officer receives Ordinary Share award under incentive plan
AstraZeneca (AZN) officer receives Ordinary Share award under incentive plan
Stock Titan · 7 days ago
How AstraZeneca’s $50 billion investment is shaping the future of medicine
How AstraZeneca’s $50 billion investment is shaping the future of medicine
KUTV · 7 days ago
Top Stock Reports for Applied Materials, GE & AstraZeneca
Top Stock Reports for Applied Materials, GE & AstraZeneca
Zacks Investment Research · 7 days ago
FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris
FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris
Zacks Investment Research · 7 days ago
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
Yahoo Finance · 7 days ago